This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Designed by European Vaccine Initiative

Description of service

Users can ship their antigens to the Vaccine Formulation Institute (VFI) for formulation with one of a variety of the VFI’s adjuvants (the VFI has a wide range and grade of adjuvants available within its portfolio). Users can request a specific adjuvant or ask the VFI for recommendations or advice. Antigens will be optimally formulated with the selected adjuvant(s) and in vitro characterisation and short-term stability studies performed. If required and feasible, antigen characterisation may also be performed. Training can also be provided in certain circumstances. A summary of the results of the formulation/stability studies obtained with each formulation will be provided to the user.


Project duration approximately 2 months


Dr. Maria Lawrenz 


Adjuvant and formulation services

Paid Service

Services do NOT include

Please contact the service provider to discuss your study outline.

Possible Output

Summary of results.

Sample Requirements - input of users

Various. To be discussed before starting.

Lead Scientist

Dr. Thomas Courant